论文部分内容阅读
[目的]探究酪酸梭菌、婴儿型双歧杆菌二联活菌制剂治疗儿科3种不同类型腹泻(小儿生理性、喂养不当、乳糖不耐受所致)的疗效观察。[方法]选取40例腹泻患儿,按照治疗方式的不同将其分为对照组和试验组,每组20例。对照组采用常规治疗方式,试验组在对照组治疗的基础上给予酪酸梭菌、婴儿型双歧杆菌二联活菌制剂。观察并比较2组患儿3种不同类型腹泻的临床疗效。[结果]经治疗后,试验组的总有效率(95.00%)明显高于对照组的总有效率(70.00%)、试验组的不良反应率(5.00%)明显低于对照组的不良反应率(30.00%),差异均有统计学意义(P<0.05)。[结论]运用酪酸梭菌、婴儿型双歧杆菌二联活菌制剂治疗最常见3种不同类型腹泻患儿,临床疗效明显好于常规治疗方式,值得临床推广应用。
[Objective] To investigate the efficacy of Clostridium butyricum and Bifidobacterium infantis in the treatment of 3 different types of pediatric diarrhea (pediatric physiological, improper feeding, lactose intolerance). [Method] Forty infants with diarrhea were selected and divided into control group and trial group according to different treatment methods, with 20 cases in each group. The control group was treated by routine treatment. The experimental group was given Clostridium butyricum and Bifidobacterium infantis viable together on the basis of the control group. The clinical effects of 3 different types of diarrhea in 2 groups were observed and compared. [Results] After treatment, the total effective rate (95.00%) in the experimental group was significantly higher than that in the control group (70.00%). The adverse reaction rate (5.00%) in the experimental group was significantly lower than that in the control group (30.00%), the differences were statistically significant (P <0.05). [Conclusion] The treatment of Clostridium butyricum and Bifidobacterium infantis viable together with Bifidobacterium infantis in the treatment of the most common 3 kinds of diarrhea patients has better clinical curative effect than conventional treatment and is worth popularizing.